Showing 281 - 300 results of 319 for search '"Organ transplantation"', query time: 0.08s Refine Results
  1. 281

    Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis by Naoki Yoshikawa, Yukina Ehara, Yusei Yamada, Yuki Matsusaki, Kazuya Shimoda, Ryuji Ikeda

    Published 2025-01-01
    “…Abstract Intra-patient variability in immunosuppressive blood drug concentrations is a potential biomarker in managing organ transplant patients. However, the association between the time in therapeutic range of tacrolimus blood concentrations and its efficacy in preventing graft-versus-host disease remains unknown. …”
    Get full text
    Article
  2. 282
  3. 283
  4. 284

    Fluconazole-Like Compounds as Potential Antifungal Agents: QSAR, Molecular Docking, and Molecular Dynamics Simulation by Farnaz Salehi, Leila Emami, Zahra Rezaei, Soghra Khabnadideh, Behnaz Tajik, Razieh Sabet

    Published 2022-01-01
    “…Today, fungal infection has become more common disease especially in some cases, such as AIDS, cancer, and organ transplant which the immune system is suppressed. …”
    Get full text
    Article
  5. 285

    The Potential of Neonatal Organ Donation in Central Sweden by Emil Bluhme, Ewa Henckel, Boubou Hallberg, Carl Jorns

    Published 2025-01-01
    “…Pediatric organ transplant recipients have a higher risk for wait list mortality due to the scarcity of size matched organs. …”
    Get full text
    Article
  6. 286

    Effect of multiorgan abdominal ischemic preconditioning on experimental kidney transplantation by Juan Cruz Abate, Ivana Ivanoff Marinoff, Nathalie Arnal, Mariana Machuca, Rodrigo Papa-Gobbi, Leandro Vecchio, Martín Rumbo, Pablo Stringa, Natalia Raquel Lausada

    Published 2024-12-01
    “…ABSTRACT Purpose: To mitigate ischemia-reperfusion injury (IRI) triggered in solid organ transplant procedures, we aimed to evaluate the effects of multi-organ abdominal ischemic preconditioning (MAIP) in the context of renal IRI. …”
    Get full text
    Article
  7. 287

    3D-Printing of Artificial Aortic Heart Valve Using UV-Cured Silicone: Design and Performance Analysis by Atila Ertas, Erik Farley-Talamantes, Olkan Cuvalci, Ozhan Gecgel

    Published 2025-01-01
    “…The advancement of medical 3D printing technology includes several enhancements, such as decreasing the length of surgical procedures and minimizing anesthesia exposure, improving preoperative planning, creating personalized replicas of tissues and bones specific to individual patients, bioprinting, and providing alternatives to human organ transplants. The range of materials accessible for 3D printing within the healthcare industry is significantly narrower when compared with conventional manufacturing techniques. …”
    Get full text
    Article
  8. 288

    Defining the Need for Causal Inference to Understand the Impact of Social Determinants of Health: A Primer on Behalf of the Consortium for the Holistic Assessment of Risk in Transp... by Nrupen A. Bhavsar, PhD, Rachel E. Patzer, PhD, David J. Taber, PharmD, Katie Ross-Driscoll, PhD, Rhiannon Deierhoi Reed, PhD, Juan C. Caicedo-Ramirez, MD, Elisa J. Gordon, PhD, MPH, Roland A. Matsouaka, PhD, Ursula Rogers, BS, Wendy Webster, MBA, Andrew Adams, MD, PhD, Allan D. Kirk, MD, Lisa M. McElroy, MD

    Published 2023-12-01
    “…This study aims to introduce key concepts and methods that inform the design of studies that seek to quantify the causal effect of social determinants of health (SDOH) on access to and outcomes following organ transplant. Background:. The causal pathways between SDOH and transplant outcomes are poorly understood. …”
    Get full text
    Article
  9. 289

    Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the F... by David A. Van Eijndhoven, Robin Vos, Robin Vos, Saskia Bos, Saskia Bos

    Published 2025-02-01
    “…A systematic search of PubMed/MEDLINE, Embase and Cochrane was conducted for studies reporting clinical outcomes of adult LTR or solid organ transplant recipients (SOTR) including LTR with drug-specific outcomes. …”
    Get full text
    Article
  10. 290
  11. 291

    Blood Borne Viral Infections in Transplantation: Hepatitis Viruses and Retroviruses by RP Bryce Larke

    Published 1993-01-01
    “…Highly sensitive assays that can be completed very rapidly are needed to ensure greater safely for the recipient of an emergency organ transplant, where time to screen a prospective donor for infectious diseases may be extremely limited.…”
    Get full text
    Article
  12. 292
  13. 293

    Differential Expression of Sphingosine-1-Phosphate Receptors in Abdominal Aortic Aneurysms by Z. Qu, Bernice L. Y. Cheuk, Stephen W. K. Cheng

    Published 2012-01-01
    “…Aortic specimens were harvested during aortic reconstructive surgery for the AAA group or during organ transplant for the control group. The protein expression of S1P1, 2 and 3 in AAAs and normal aortas was assessed by Western blotting and immunohistochemical analysis. …”
    Get full text
    Article
  14. 294

    Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients by Chaiho Jeong, Hee-Je Kim, Seok Lee, Moo Il Kang, Jeonghoon Ha

    Published 2020-01-01
    “…The effect of denosumab in solid organ transplant recipients has been elucidated, but its effect in haematopoietic stem cell transplantation recipients has not been studied yet. …”
    Get full text
    Article
  15. 295

    Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study by Renita Wilson, BS, J. Asher Jenkins, MD, Juan Maria Farina, MD, Blake Langlais, MS, Bashar Aqel, MD, Ashraf Omar, MD, Jonathan D’Cunha, MD PhD, Pedro Reck dos Santos, MD PhD

    Published 2025-02-01
    “…Methods: The ISHLT International Thoracic Organ Transplant Registry was queried for patients <18 years old with CF who underwent ConLi-LTx and LTx-only from 1994-June 2018. …”
    Get full text
    Article
  16. 296

    Risk Factors for Sepsis Based on Sepsis-3 Criteria after Orthotopic Liver Transplantation by Yanling Wang, Yu Gu, Fei Huang, Dezhao Liu, Zheng Zhang, Niman Zhou, Jiani Liang, Changyin Lu, Dongdong Yuan, Ziqing Hei

    Published 2018-01-01
    “…Sepsis is a common complication of solid organ transplant procedures and, in particular, can affect the prognosis of orthotopic liver transplantation (OLT). …”
    Get full text
    Article
  17. 297

    Study of Lophomonas blattarum Infection in Kidney Transplant Patients in Mashhad City, Iran by Zahra Gheisari, Fariba Berenji, Fatemeh Nazemian, Seyed Ali Akbar Shamsian, Lida Jarahi, Mahmoud Parian, Bibi Razieh Hosseini Farash, Ghodratollah Salehi Sangani

    Published 2020-01-01
    “…Lophomonas blattarum is a flagellate protozoan which is known as an emerging parasite in the human respiratory system. Organ transplant recipients are considered as immunocompromised patients due to prescription of immunosuppressive drugs. …”
    Get full text
    Article
  18. 298

    Inherited metabolic diseases are a potent risk factor for cytomegalovirus infection in pediatric living donor liver transplantation by Kentaro Ushijima, Yukihiro Sanada, Shinya Otomo, Keiko Ogaki, Taiichi Wakiya, Noriki Okada, Yuta Hirata, Toshio Horiuchi, Takahiko Omameuda, Kiichiro Takadra, Ryosuke Akimoto, Yasuharu Onishi, Yasunaru Sakuma, Koichi Mizuta

    Published 2025-01-01
    “…Abstract Background Cytomegalovirus (CMV) is a major infectious complication in solid-organ transplant recipients, particularly in the context of pediatric liver transplantation. …”
    Get full text
    Article
  19. 299

    Speckled-egg staining appearance of cryptococcal osteomyelitis in an immunocompetent patient by Matthew Alexander Stack, John-Paul Lavik, Jack G. Schneider, Brynne E. Cross

    Published 2025-01-01
    “…Introduction: Cryptococcal infections are typically thought of as occurring in immunocompromised patients, such as patients with HIV/AIDS, solid organ transplant recipients, or patients with rheumatologic diseases that require immunomodulatory therapy. …”
    Get full text
    Article
  20. 300

    Mucosal Epithelial Jak Kinases in Health and Diseases by Narendra Kumar, Longxiang Kuang, Ryan Villa, Priyam Kumar, Jayshree Mishra

    Published 2021-01-01
    “…A selective Jak3 inhibitor CP-690550 (Xeljanz) approved by the FDA for certain chronic inflammatory conditions demonstrates immunosuppressive activity in rheumatoid arthritis, psoriasis, and organ transplant rejection. Here, we also focus on the consequences of Jak3-directed drugs on adverse effects in light of recent discoveries in mucosal epithelial functions of Jak3 with some information on other Jaks. …”
    Get full text
    Article